Köse 1997.

Methods	DESIGN Between‐patient Delivery unclear ALLOCATION Random Method of randomisation: not stated Concealment: unclear BLINDING Unclear WITHDRAWAL/DROPOUT Described
Participants	N: 43 Treatment duration: 10 days FU: 20 days LF: 0 (0%) BC: yes Age: not stated Gender (per cent men): not stated Severity: not stated INCLUSION CRITERIA Psoriasis of the scalp EXCLUSION CRITERIA Not reported
Interventions	Calcipotriol ointment 50 mcg/g occluded ON (CO) Clobetasol 17‐propionate solution BD (CP)
Outcomes	TSS (0 to 9)
Notes	The trial did not report sponsorship. This was a scalp trial.
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	The trial reported insufficient details.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	The trial did not report this.
Randomisation method reported	Unclear risk	The trial did not report this.
Loss to follow up	Low risk	0.0%
Baseline assessments	Unclear risk	The trial did not report these.
Baseline comparability demonstrated	Unclear risk	The trial reported baseline comparability (demographic/clinical), but it was not demonstrated.